Chronic traumatic encephalopathy (CTE): criteria for neuropathological diagnosis and relationship to repetitive head impacts

AC McKee, TD Stein, BR Huber, JF Crary… - Acta …, 2023 - Springer
Over the last 17 years, there has been a remarkable increase in scientific research
concerning chronic traumatic encephalopathy (CTE). Since the publication of NINDS–NIBIB …

Tau-targeting therapies for Alzheimer disease: current status and future directions

EE Congdon, C Ji, AM Tetlow, Y Jiang… - Nature Reviews …, 2023 - nature.com
Alzheimer disease (AD) is the most common cause of dementia in older individuals. AD is
characterized pathologically by amyloid-β (Aβ) plaques and tau neurofibrillary tangles in the …

Tau and neuroinflammation in Alzheimer's disease: Interplay mechanisms and clinical translation

Y Chen, Y Yu - Journal of neuroinflammation, 2023 - Springer
Alzheimer's Disease (AD) contributes to most cases of dementia. Its prominent
neuropathological features are the extracellular neuritic plaques and intercellular …

Targeted dephosphorylation of tau by phosphorylation targeting chimeras (PhosTACs) as a therapeutic modality

Z Hu, PH Chen, W Li, T Douglas, J Hines… - Journal of the …, 2023 - ACS Publications
Microtubule-associated protein tau is essential for microtubule assembly and stabilization.
Hyperphosphorylation of the microtubule-associated protein tau plays an important …

Cytosolic antibody receptor TRIM21 is required for effective tau immunotherapy in mouse models

AS Mukadam, LVC Miller, AE Smith, M Vaysburd… - Science, 2023 - science.org
Aggregates of the protein tau are proposed to drive pathogenesis in neurodegenerative
diseases. Tau can be targeted by using passively transferred antibodies (Abs), but the …

TRIM11 protects against tauopathies and is down-regulated in Alzheimer's disease

ZY Zhang, DS Harischandra, R Wang, S Ghaisas… - Science, 2023 - science.org
Aggregation of tau into filamentous inclusions underlies Alzheimer's disease (AD) and
numerous other neurodegenerative tauopathies. The pathogenesis of tauopathies remains …

[HTML][HTML] Disease-modifying therapies for Alzheimer's disease: more questions than answers

TE Golde - Neurotherapeutics, 2023 - Elsevier
Scientific advances over the last four decades have steadily infused the Alzheimer's disease
(AD) field with great optimism that therapies targeting Aβ, amyloid, tau, and innate immune …

Cis P-tau is a central circulating and placental etiologic driver and therapeutic target of preeclampsia

S Jash, S Banerjee, S Cheng, B Wang, C Qiu… - Nature …, 2023 - nature.com
Preeclampsia (PE) is the leading cause of maternal and fetal mortality globally and may
trigger dementia later in life in mothers and their offspring. However, the etiological drivers …

Lifetime traumatic brain injury and cognitive domain deficits in late life: the PROTECT-TBI cohort study

MJ Lennon, H Brooker, B Creese… - Journal of …, 2023 - liebertpub.com
Traumatic brain injury (TBI) causes cognitive impairment but it remains contested regarding
which cognitive domains are most affected. Further, moderate-severe TBI is known to be …

Disrupting pathologic phase transitions in neurodegeneration

BT Hurtle, L Xie, CJ Donnelly - The Journal of clinical …, 2023 - Am Soc Clin Investig
Solid-like protein deposits found in aged and diseased human brains have revealed a
relationship between insoluble protein accumulations and the resulting deficits in neurologic …